Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-22 | Mr. Macdonald received an Honors Degree in biochemistry from Dundee University in Dundee, Scotland. |
| 2016-04-21 | Mr. Macdonald received an Honors Degree in biochemistry from Dundee University in Dundee, Scotland. Because of Mr. Macdonald’s extensive experience in drug development and commercialization, particularly with anti-infectives, including antifungals, we believe he is able to make valuable contributions to our Board. |
| 2017-04-26 | Mr. Macdonald received an Honors Degree in biochemistry from Dundee University in Dundee, Scotland. Because of Mr. Macdonald's extensive experience in drug development and commercialization, particularly with anti-infectives, including antifungals, we believe he is able to make valuable contributions to our Board. |
| 2018-04-30 | Mr. Macdonald received an Honors Degree in biochemistry from Dundee University in Dundee, Scotland. Because of Mr. Macdonald’s extensive experience in drug development and commercialization, particularly with anti-infectives, including antifungals, we believe he is able to make valuable contributions to our Board. |
| 2019-05-07 | Mr. Macdonald has served as the President and Chief Executive Officer of Tetraphase Pharmaceuticals, Inc. and held various positions at Merck & Co. |
| 2020-05-29 | Mr. Macdonald received an Honors Degree in biochemistry from Dundee University... extensive experience in drug development and commercialization. |
| 2021-04-26 | Mr. Macdonald received an Honors Degree in biochemistry from Dundee University in Dundee, Scotland. Because of Mr. Macdonald’s extensive experience in drug development and commercialization, particularly with anti-infectives, including antifungals, we believe he is able to make valuable contributions to our Board. |
| 2022-05-12 | Mr. Macdonald received an Honors Degree in biochemistry from Dundee University in Dundee, Scotland. Because of Mr. Macdonald’s extensive experience in drug development and commercialization, particularly with anti-infectives, including antifungals, we believe he is able to make valuable contributions to our Board. |
| 2022-08-19 | Guy Macdonald |
| 2023-05-01 | Mr. Macdonald served as President and CEO of Tetraphase Pharmaceuticals and held various positions at Merck & Co. He received an Honors Degree in biochemistry. |
| 2024-04-25 | Mr. Macdonald received an Honors Degree in biochemistry from Dundee University in Dundee, Scotland. Because of Mr. Macdonald’s extensive experience in drug development and commercialization, particularly with anti-infectives, including antifungals, we believe he is able to make valuable contributions to our Board. |
Data sourced from SEC filings. Last updated: 2026-02-03